The research team at The Queen Elizabeth Hospital in King’s Lynn has received £20,000 funding following its success in clinical trials.
The Department of Health and Social Care (DHSC) has awarded the money after the team surpassed a 500-patient target to participate in research for new treatments.
The 10-strong team at the Gayton Road hospital has already played a role in the clinical trials for developing a number of new drugs, including Tolvaptan, which is used to treat polycystic kidney disease.
The team has also been involved with testing a new device to check blood sugar levels for people with type one diabetes.
Over the last year, the team has recruited more than 800 people to take part in trials.
Antonia Hardcastle, research and innovation lead, said: “We are delighted to receive the money, it will help us grow the team so that we can offer patients better care and innovative treatments.
“This money will enable us to pay for staff to continue the good work that we have already started.”
For more about the QEH’s work see www.qehkl.nhs.uk